CD44-targeting hyaluronic acid-selenium nanoparticles boost functional recovery following spinal cord injury

Wenqi Luo,Yueying Li,Jianhui Zhao,Renrui Niu,Chunyu Xiang,Mingyu Zhang,Chunsheng Xiao,Wanguo Liu,Rui Gu

DOI: https://doi.org/10.1186/s12951-024-02302-0

IF: 10.2

2024-01-25

Journal of Nanobiotechnology

Abstract:Therapeutic strategies based on scavenging reactive oxygen species (ROS) and suppressing inflammatory cascades are effective in improving functional recovery after spinal cord injury (SCI). However, the lack of targeting nanoparticles (NPs) with powerful antioxidant and anti-inflammatory properties hampers the clinical translation of these strategies. Here, CD44-targeting hyaluronic acid-selenium (HA-Se) NPs were designed and prepared for scavenging ROS and suppressing inflammatory responses in the injured spinal cord, enhancing functional recovery.

biotechnology & applied microbiology,nanoscience & nanotechnology

What problem does this paper attempt to address?

This paper mainly discusses how to use CD44-targeted hyaluronic acid-selenium nanoparticles (HA-Se NPs) to improve functional recovery after spinal cord injury (SCI). In the study, the authors designed and prepared HA-Se NPs that can scavenge reactive oxygen species (ROS) and inhibit inflammatory reactions to alleviate secondary damage after spinal cord injury. The experimental results showed that these nanoparticles have excellent free radical scavenging ability and can be internalized by astrocytes through the CD44 receptor. HA-Se NPs can also reduce the secretion of pro-inflammatory cytokines (such as IL-1β, TNF-α, and IL-6) from microglia in lipopolysaccharide-induced inflammation. In vivo experiments showed that HA-Se NPs targeted to the injury site through CD44 aggregation, protecting axons and neurons, thereby promoting functional recovery in a rat SCI model. Therefore, this study highlights the potential of CD44-targeted HA-Se NPs in the treatment of spinal cord injury.